These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 23328431
21. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds. Lopes AM, Chen KY, Kamei DT. Mater Sci Eng C Mater Biol Appl; 2017 Apr 01; 73():373-380. PubMed ID: 28183621 [Abstract] [Full Text] [Related]
22. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Wang C, Ho PC, Lim LY. Int J Pharm; 2010 Nov 15; 400(1-2):201-10. PubMed ID: 20804835 [Abstract] [Full Text] [Related]
23. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer. Jiménez-López J, El-Hammadi MM, Ortiz R, Cayero-Otero MD, Cabeza L, Perazzoli G, Martin-Banderas L, Baeyens JM, Prados J, Melguizo C. Pharmacol Res; 2019 Mar 15; 141():451-465. PubMed ID: 30634051 [Abstract] [Full Text] [Related]
29. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. Khan AM, Ahmad FJ, Panda AK, Talegaonkar S. Int J Pharm; 2016 Jun 30; 507(1-2):61-71. PubMed ID: 27154254 [Abstract] [Full Text] [Related]
30. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schäller S, Bakowsky U, Kissel T. J Control Release; 2007 May 14; 119(1):41-51. PubMed ID: 17346845 [Abstract] [Full Text] [Related]
33. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution. Mandal D, Shaw TK, Dey G, Pal MM, Mukherjee B, Bandyopadhyay AK, Mandal M. Int J Biol Macromol; 2018 Jun 14; 112():818-830. PubMed ID: 29421493 [Abstract] [Full Text] [Related]
34. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B, Ranganathan B, Feng SS. Biomaterials; 2008 Feb 14; 29(4):475-86. PubMed ID: 17953985 [Abstract] [Full Text] [Related]
35. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Feng SS, Zeng W, Teng Lim Y, Zhao L, Yin Win K, Oakley R, Hin Teoh S, Hang Lee RC, Pan S. Nanomedicine (Lond); 2007 Jun 14; 2(3):333-44. PubMed ID: 17716178 [Abstract] [Full Text] [Related]
36. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin. Zhang X, Li J, Yan M. Drug Dev Ind Pharm; 2016 Oct 14; 42(10):1590-9. PubMed ID: 26942448 [Abstract] [Full Text] [Related]
40. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X. Int J Pharm; 2012 Oct 15; 436(1-2):815-24. PubMed ID: 22846410 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]